Lung bioavailability of generic and innovator salbutamol MDIs.
作者信息
Chrystyn H, Corlett S A, Silkstone V
出版信息
Thorax. 1996 Jun;51(6):658. doi: 10.1136/thx.51.6.658.
Abstract
摘要
相似文献
1
Lung bioavailability of generic and innovator salbutamol MDIs.仿制和原创沙丁胺醇定量吸入气雾剂的肺部生物利用度。
Thorax. 1996 Jun;51(6):658. doi: 10.1136/thx.51.6.658.
2
Lung bioavailability of generic and innovator salbutamol metered dose inhalers.仿制和创新型沙丁胺醇定量气雾剂的肺部生物利用度。
Thorax. 1996 Mar;51(3):325-6. doi: 10.1136/thx.51.3.325.
3
Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device.多次按压、延迟吸入及抗静电处理对沙丁胺醇经储雾罐装置的肺部生物利用度的影响
Thorax. 1996 Oct;51(10):981-4. doi: 10.1136/thx.51.10.981.
4
Lung bioavailability of spacers.储雾罐的肺部生物利用度。
Ann Allergy Asthma Immunol. 2003 Jun;90(6):674; author reply 674-5. doi: 10.1016/S1081-1206(10)61876-5.
5
Bioavailability Study of Niosomal Salbutamol Sulfate in Metered Dose Inhaler: Controlled Pulmonary Drug Delivery.硫酸沙丁胺醇脂质体定量吸入器的生物利用度研究：可控肺部药物递送
J Aerosol Med Pulm Drug Deliv. 2018 Apr;31(2):114-115. doi: 10.1089/jamp.2017.1448. Epub 2018 Feb 16.
6
[Studies on the pharmacokinetics and relative bioavailability of salbutamol aerosol in healthy volunteers].[健康志愿者中沙丁胺醇气雾剂的药代动力学及相对生物利用度研究]
Yao Xue Xue Bao. 2001 Aug;36(8):616-20.
7
Salbutamol relative lung and systemic bioavailability of large and small spacers.
J Pharm Pharmacol. 2008 Dec;60(12):1609-13. doi: 10.1211/jpp/60.12.0006.
8
Evaluation of an in vitro in vivo correlation for nebulizer delivery using artificial neural networks.
J Pharm Sci. 2007 Dec;96(12):3293-303. doi: 10.1002/jps.20965.
9
Pharmacokinetics and relative bioavailability of salbutamol metered-dose inhaler in healthy volunteers.沙丁胺醇定量气雾剂在健康志愿者中的药代动力学及相对生物利用度
Acta Pharmacol Sin. 2002 Jul;23(7):663-6.
10
Lung deposition and systemic bioavailability of different aerosol devices with and without humidification in mechanically ventilated patients.机械通气患者中不同雾化装置在有或无湿化情况下的肺部沉积及全身生物利用度。
Heart Lung. 2017 Nov-Dec;46(6):464-467. doi: 10.1016/j.hrtlng.2017.08.004. Epub 2017 Sep 4.
引用本文的文献
1
Deposition and effects of inhaled corticosteroids.吸入性糖皮质激素的沉积与作用
Clin Pharmacokinet. 2003;42(6):529-44. doi: 10.2165/00003088-200342060-00003.
2
Pharmacokinetics and systemic beta2-adrenoceptor-mediated responses to inhaled salbutamol.吸入沙丁胺醇的药代动力学及全身β2-肾上腺素能受体介导的反应
Br J Clin Pharmacol. 2001 Apr;51(4):359-62. doi: 10.1046/j.1365-2125.2001.01362.x.
3
Methods to identify drug deposition in the lungs following inhalation.识别吸入后药物在肺部沉积的方法。
Br J Clin Pharmacol. 2001 Apr;51(4):289-99. doi: 10.1046/j.1365-2125.2001.01304.x.
4
Effect of electrostatic charge in plastic spacers on the lung delivery of HFA-salbutamol in children.塑料间隔器中的静电荷对儿童中氢氟烷烃沙丁胺醇肺部给药的影响。
Br J Clin Pharmacol. 1999 Mar;47(3):333-6. doi: 10.1046/j.1365-2125.1999.00893.x.
5
Early lung absorption profile of non-CFC salbutamol via small and large volume plastic spacer devices.非氯氟烃沙丁胺醇通过小容量和大容量塑料储雾罐装置的早期肺部吸收情况。
Br J Clin Pharmacol. 1998 Jul;46(1):45-8. doi: 10.1046/j.1365-2125.1998.00041.x.
6
Effects of airway calibre on lung delivery of nebulised salbutamol.气道口径对雾化沙丁胺醇肺部给药的影响。
Thorax. 1997 Dec;52(12):1036-9. doi: 10.1136/thx.52.12.1036.
7
Lung delivery of non-CFC salbutamol via small volume metal spacer and large volume plastic spacer devices compared with an open vent jet nebulizer.通过小容量金属储雾罐和大容量塑料储雾罐装置与开放式喷射雾化器相比，非氯氟烃沙丁胺醇的肺部给药。
Br J Clin Pharmacol. 1998 Feb;45(2):160-3. doi: 10.1046/j.1365-2125.1998.00648.x.
本文引用的文献
1
Determination of the relative bioavailability of salbutamol to the lung following inhalation.吸入后沙丁胺醇在肺部的相对生物利用度的测定。
Br J Clin Pharmacol. 1992 Oct;34(4):311-5. doi: 10.1111/j.1365-2125.1992.tb05921.x.
Zotero 插件